RxNorm 863829 NDC Crossover
CREON 24,000 UNT / 120,000 UNT / 76,000 UNT Delayed Release Oral Capsule
Related NDC Codes to RxNorm Concept 863829
The following NDC codes crossover to the RxNorm Concept 863829. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
0032-0045 | Creon | Pancrelipase | Capsule, Delayed Release | Oral | Abbvie Inc. | ACTIVE | |
0032-0046 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | ACTIVE | |
0032-0047 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | ACTIVE | |
0032-1203 | Creon | Pancrelipase | Capsule, Delayed Release | Oral | Abbvie Inc. | ACTIVE | |
0032-1206 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | ACTIVE | |
0032-1212 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | ACTIVE | |
0032-1224 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | ACTIVE | |
0032-2636 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | ACTIVE | |
0032-2637 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | ACTIVE | |
0032-3016 | Creon | Pancrelipase | Capsule, Delayed Release Pellets | Oral | Abbvie Inc. | ACTIVE | |
17856-1224 | Creon | Atlantic Biologicals Corps | INACTIVATED |